Provention Bio Inc. (PRVB) Tops Q2 EPS by 4c

Provention Bio Inc. (NASDAQ: PRVB) reported Q2 EPS of ($0.46), $0.04 better than the analyst estimate of ($0.50). Revenue for the quarter came in at $746 thousand versus the consensus estimate of $696.67 thousand.

For earnings history and earnings-related data on Provention Bio Inc. (PRVB) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Yum! Brands (YUM) PT Lowered to $180 at Argus
• DA Davidson Reiterates Buy Rating on Boost Run (BRUN)